Canadian application, no grantCanada
Methods for detecting and inhibiting the rna component of telomerase
CA 2274586 A1 · Owner: Kealey, James T. · Inventors: Kealey, James T.; Weinrich, Scott L.; Wu, Fred
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of detecting the RNA component of telomerase diagnosing cancer, determining its prognosis and inhibiting telomerase activity using polynucleotides that hybridize to the RNA component of mammalian telomerase.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 19, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 19, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 19, 1997
GrantedNo grant recorded
Term endedDecember 19, 2017
Patent numberCA 2274586 A1
Classification (IPC)C12Q1/68 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.